Retinal Vessel Diameters and the Incidence of Gross Proteinuria and Renal Insufficiency in People With Type 1 Diabetes
|
|
- Julian Weaver
- 5 years ago
- Views:
Transcription
1 Retinal Vessel Diameters and the Incidence of Gross Proteinuria and Renal Insufficiency in People With Type 1 Diabetes Tien Yin Wong, 1,2 Anoop Shankar, 3 Ronald Klein, 3 and Barbara E.K. Klein 3 Early retinal vessel caliber changes may predict risk of diabetic nephropathy. We examined the association of retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in a populationbased cohort of people with type 1 diabetes (n 557). Baseline retinal photographs were digitized, and diameters of individual retinal vessels were measured and summarized. Incident cases of gross proteinuria and renal insufficiency were identified over a 16-year period. Larger retinal venular diameter was associated with higher cumulative incidence of gross proteinuria (18.6, 25.4, 37.7, and 50.4%, comparing increasing venular diameter quartiles) and renal insufficiency (10.7, 15.5, 23.2, and 32.8%). After adjusting for age, sex, duration of diabetes, HbA 1c levels, baseline retinopathy levels, and other factors, larger retinal venular diameter was associated with an increased risk of gross proteinuria (RR 1.53, 95% CI , comparing 4th vs. 1st to 3rd quartiles of venular diameter) and renal insufficiency (1.51, ). Retinal arteriolar diameter was not associated with either gross proteinuria or renal insufficiency. We conclude that in individuals with type 1 diabetes, larger retinal venular diameter is independently associated with the long-term incidence of gross proteinuria and renal insufficiency and may provide additional predictive information regarding risk of nephropathy. Diabetes 53: , 2004 From the 1 Centre for Vision Research, University of Melbourne, Melbourne, Australia; the 2 Department of Ophthalmology, National University of Singapore, Eye Research Institute, Singapore; and the 3 Department of Ophthalmology, University of Wisconsin, Madison, Wisconsin. Address correspondence and reprint requests to Tien Yin Wong, MD, PhD, Centre for Eye Research Australia, Department of Ophthalmology, University of Melbourne, 32 Gisborne St., East Melbourne 3002, Australia. ophwty@nus.edu.sg. Received for publication 19 May 2003 and accepted in revised form 6 October GFR, glomerular filtration rate; WESDR, Wisconsin Epidemiologic Study of Diabetic Retinopathy by the American Diabetes Association. Although diabetes accounts for 42% of end-stage renal disease in the U.S. (1), current methods to predict people at risk of diabetic nephropathy remain inadequate (2,3). Microangiopathy is believed to be a key pathogenic mechanism in the development of diabetic nephropathy (4 6), and approaches that identify early stages of microvascular disease may potentially provide information regarding risk of this complication in individuals with diabetes. The retinal microcirculation, accessible to direct noninvasive visualization, shares similar physiological and pathological characteristics with the renal microcirculation (7 9). Previous studies have documented the strong association between advanced stages of diabetic retinal disease (e.g., proliferative retinopathy) and nephropathy (10 15). However, the relationship of early retinal vessel caliber changes (e.g., arteriolar narrowing and venular dilatation) and risk of diabetic nephropathy is unknown, although altered retinal blood flow is clearly linked with the pathogenesis of diabetes (16 22). In the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), a population-based study of people with diabetes, we recently used a computer-assisted method to measure retinal vessel diameters from digitized fundus photographs (23). We have shown that narrowed retinal arterioles and dilated venules were related to severity of diabetic retinopathy, independent of duration of disease, glycemic control, blood pressure, and other risk factors. In the current study, we prospectively examine the association of retinal arteriolar and venular diameters and the 16-year incidence of gross proteinuria and renal insufficiency in the WESDR cohort. RESEARCH DESIGN AND METHODS The WESDR has been described in detail in earlier publications (24,25). In brief, a probability sample of 10,135 diabetic patients who received primary care in an 11-county area in southern Wisconsin from 1979 to 1980, composed of younger-onset and older-onset individuals, was invited to participate in the baseline examination conducted from 1980 to 1982 (24,25). These analyses will be limited to the group of younger-onset individuals who were taking insulin and had been diagnosed before 30 years of age (n 1,210). The second examination was conducted at 4 years ( ) (26), the third at 10 years ( ) (27), the fourth at 14 years ( ) (28), and the fifth at 20 years ( ) from the baseline examination. Reasons for nonparticipation and comparisons between participants and nonparticipants at baseline and follow-up examinations have been presented previously (24 28). All examinations were performed in a mobile examination van in or near the cities where the participants resided, following a similar protocol that was conducted according to the principles expressed in the Declaration of Helsinki, and was approved by the Institutional Human Subjects Committee of the University of Wisconsin. Serum creatinine was first measured from the second examination ( ) onwards (12). Of the 903 participants who participated in the second examination, we excluded (nonexclusively) those individuals with preexisting renal disease (urine protein level 0.3 g/l [n 195], estimated glomerular filtration rate [GFR] 90 ml min m 2 [n 152], positive history of dialysis [n 43], or history of renal transplantation [n 41]); missing serum creatinine levels (n 36); a history of pancreas transplantation (n 3); missing information on important covariates: HbA 1c levels [n 28], BMI [n 10], alcohol and smoking history [n 28], and systolic or diastolic blood pressure [n 30]); and younger than 18 years of age (n 8). We also excluded those who did not participate in the subsequent examinations and those with urine ketone levels 15 mg/dl (n 29), since the latter could have interfered with serum creatinine measurements (29). This resulted in the DIABETES, VOL. 53, JANUARY
2 RETINAL VESSEL DIAMETERS AND RENAL DYSFUNCTION TABLE 1 Baseline characteristics of study population in relation to quartiles of retinal venular diameter Retinal venular diameter 1st quartile 2nd quartile 3rd quartile 4th quartile P* n Age (years) Men (%) Duration of diabetes (years) Family income ($10,000) Years of schooling Cigarette smoking (pack-years) Alcohol intake (.02 day) BMI (kg/m 2 ) HbA 1c (%) Systolic blood pressure (mmhg) Diastolic blood pressure (mmhg) Total cholesterol (mg/dl) HDL cholesterol (mg/dl) Data are percent. Range of values for retinal venular diameters (in micrometers): 4th quartile , 3rd quartile , 2nd quartile , 1st quartile *P represents difference in characteristics by AVR quartiles ANOVA or 2 tests as appropriate. inclusion of 557 individuals at risk of incident gross proteinuria and renal insufficiency. Assessment of retinal vessel diameters. Retinal vessel diameters were measured at the baseline examination using a computer-assisted technique based on a standard protocol and formula for the Atherosclerosis Risk in Communities Study described in detail elsewhere (30). For WESDR, retinal photographs of field 1 at the baseline examination were converted to digital images by a high-resolution scanner using identical settings for all photographs (23). Trained graders masked to participant characteristics measured the diameters of all arterioles and venules coursing through a specified area one-half to one disc diameter surrounding the optic disc using a computer software program (Retinal Analysis; Optimate, Madison, WI). On average, between 7 and 14 arterioles, and an equal number of venules, were measured per eye. Individual arteriolar and venular measurements were combined into summary indexes that reflected the average retinal arteriolar and venular diameter of an eye, based on the Parr-Hubbard formula (30). Reproducibility of this retinal vessel grading approach was high, as previously reported (30). Gross proteinuria and renal insufficiency. The assessment and definition of gross proteinuria and renal insufficiency in the WESDR has been previously described (11,12). Semiquantitative determination of urinary protein excretion in casual urine samples was performed using a reagent strip test (Labstix; Ames, Elkhart, IN). Serum creatinine was measured by a method based on a modification of the Jaffe reaction, with a centrifugal analyzer (Roche Cobra FARA; Roche Diagnostics, Division of Hoffmann-La Roche, Nutley, NJ) using standard reagents (Boehringer Mannheim Diagnostic, Indianapolis, IN) (12). The imprecision of the creatinine assay was determined to be % (mean SD) and % on the basis of repeated (n 140) measurement controls with values of 1.1 and 6.2 mg/dl, respectively. The method was determined to be linear to 20.0 mg/dl. We calculated estimated GFR using the simplified equation developed from the Modification of Diet in Renal Disease study as follows: estimated GFR (serum creatinine) age (0.742 for women) (31,32). Incident gross proteinuria was defined as the development of 0.3 g/l protein excretion in a casual urine specimen (11), and incident renal insufficiency was defined as the development of estimated GFR 60 ml min m 2 (corresponding approximately to a creatinine level 1.5 mg/dl in men or 1.3 mg/dl in women) after the second examination among those at risk (12). In a subsidiary analysis, we also examined associations with incident microalbuminuria (present or absent) estimated from casual urine samples from the second examination onwards. Definition of other variables. Protocols for grading diabetic retinopathy have been described in detail elsewhere (24,25) and are modifications of the Early Treatment Diabetic Retinopathy Study adaptation of the Airlie House classification of diabetic retinopathy (33). The retinopathy level for a participant was derived by combining the diabetic retinopathy levels of two eyes. For this study, any retinopathy was defined as level 21 (presence of a single microaneurysm and hard or soft exudates) or higher and proliferative retinopathy was defined as level 60 (new vessels, fibrous proliferation, vitreous or preretinal hemorrhage, or scars of photocoagulation either in scatter or confluent patches) or higher (28). Trained personnel measured blood pressure according to the Hypertension Detection and Follow-up Program Protocol (34). The mean arterial blood pressure was computed as two-thirds of the diastolic plus one-third of the systolic value. In individuals 25 years of age or older, hypertension was defined as a systolic blood pressure 160 mmhg, diastolic blood pressure 95 mmhg, and/or a history of antihypertensive medication use at the time of examination; in younger individuals, hypertension was defined as a systolic blood pressure 140 mmhg, diastolic blood pressure 90 mmhg, and/or a history of antihypertensive medication use at the time of examination. Other pertinent procedures included collecting information on combined family income, years of schooling, year of diagnosis of diabetes, cigarette smoking and alcohol intake, standardized measurement of height and weight, and determining HbA 1c and lipid levels from a venous blood sample (24 28,35). Statistical analysis. Retinal arteriolar and venular diameter were analyzed as categorical variables (divided into quartiles, with the 1st quartile indicating the smallest and the 4th quartile the largest diameters) and also analyzed as continuous variables (per SD change in arteriolar and venular diameters). We used ANOVA models and 2 tests to compare the relationship of various baseline characteristics in association with retinal venular quartiles. Pooled logistic regression models with increments corresponding to each follow-up examination, similar to time-varying Cox proportional hazards models, were used to determine the RR of gross proteinuria and renal insufficiency, controlling simultaneously for possible confounders (36). The covariates updated with each follow-up examination included age (years), annual family income ($10,000 dollars), HbA 1c level (%), pack-years of smoking, BMI (kg/m 2 ), average alcohol intake (ounces per day), mean arterial blood pressure (mmhg), albuminuria status (categorized into none and microalbuminuria for gross proteinuria as the outcome and none, microalbuminuria, and gross proteinuria for estimated renal insufficiency as the outcome), and retinopathy. For multivariable analysis, we constructed three nested models: the first model was adjusted for age, sex, follow-up time, and annual family income; the second model was further adjusted for duration of diabetes, HbA 1c level, BMI, pack-years of smoking, average alcohol intake, mean arterial blood pressure, and albuminuria status; and the final model was further adjusted for retinopathy levels. Additionally, we tested for any interaction between retinal venular quartiles and follow-up time by including a crossproduct interaction term in the logistic regression model; there was no interaction detected (P 0.20). Finally, we performed stratified analyses within subgroups of several related variables. RESULTS Table 1 shows participant characteristics according to retinal venular diameter quartiles. In general, individuals with larger retinal venular diameter were older, more likely to have a longer duration of diabetes and higher BMI, systolic and diastolic blood pressure, and HbA 1c levels. Retinal venular diameter was not significantly related to sex, family income, education, cigarette smoking and alcohol consumption status, or lipid levels. Smaller 180 DIABETES, VOL. 53, JANUARY 2004
3 YIN WONG AND ASSOCIATES arteriolar diameter was associated with older age and increased systolic and diastolic blood pressure (data not shown). After 16 years of follow-up, 183 individuals developed incident gross proteinuria and 114 developed incident renal insufficiency. Larger retinal venular diameter was associated with higher cumulative incidence of gross proteinuria (18.6, 25.4, 37.7, and 50.4%, comparing increasing venular diameter quartiles) and renal insufficiency (10.7, 15.5, 23.2, and 32.8%, comparing increasing venular diameter quartiles). After adjusting for age, sex, follow-up time, and family income, larger retinal venular diameter was associated with an increased risk of gross proteinuria (RR 1.75, 95% CI , comparing 4th vs. 1st to 3rd quartiles of venular diameter) and renal insufficiency (1.72, ) (Table 2). These associations persisted despite controlling for duration of diabetes, HbA 1c levels, blood pressure, baseline retinopathy, and other factors. Retinal arteriolar diameter was not significantly associated with either gross proteinuria or renal insufficiency. Table 2 also shows these results with retinal venular and arteriolar diameter analyzed as a continuous variable. Each SD increase in retinal venular diameter was significantly associated with a 23% higher risk of gross proteinuria and a 22% higher risk of renal insufficiency, controlling for risk factors. Smaller retinal arteriolar diameter was not associated with increased risk of renal insufficiency. We performed several stratified analyses to examine potential effect modification for the association of larger venular diameter and risk of gross proteinuria and renal insufficiency (Table 3). The association between larger retinal venular diameter and risk of gross proteinuria and renal insufficiency was seen in individuals with and without microalbuminuria, any retinopathy, or proliferative retinopathy. Associations were also similar in men and women and in groups stratified by cigarette smoking status, BMI, and hypertension status. Finally, we performed two subsidiary analyses. First, among a subgroup of 323 individuals with information on total cholesterol and HDL cholesterol levels, additional adjustment for these factors showed a similar pattern and strength of associations as those presented in Table 2 (data not shown). Second, we examined the relationship of retinal vessel diameters to incident microalbuminuria defined from a casual urine sample from the second examination onwards. After multivariable adjustment, the incidence of microalbuminuria was associated with larger retinal venular diameter (RR 1.57, 95% CI , comparing 4th vs. 1st to 3rd quartiles of venular diameter) but was not related to arteriolar diameter. DISCUSSION In this prospective, population-based study of individuals with type 1 diabetes, larger retinal venular diameter, quantified using a new computer-assisted technique, was associated with risk of diabetic nephropathy developing over a 16-year period. Individuals with retinal venular diameter in the highest quartile of the population were 50% more likely to develop gross proteinuria and renal insufficiency than those with venular diameter in the lowest three quartiles, independent of age, sex, duration of Data are RR (95% CI). Range of values for venular diameters (in micrometers): 4th quartile , 3rd quartile , 2nd quartile , 1st quartile Range of values for arteriolar diameters (in micrometers): 1st quartile , 2nd quartile , 3rd quartile , 4th quartile *Adjusted for age, sex, follow-up time, and annual family income; adjusted for age, sex, follow-up time, annual family income, duration of diabetes, HbA 1c level, BMI, pack-years of smoking, average alcohol intake, mean arterial blood pressure, and albuminuria status; adjusted for age, sex, follow-up time, annual family income, duration of diabetes, HbA 1c level, BMI, pack-years of smoking, average alcohol intake, mean arterial blood pressure, albuminuria status, and retinopathy level. Venular diameters Quartile ( ) 1.58 ( ) 1.53 ( ) ( ) 1.55 ( ) 1.51 ( ) Quartiles (Referent) 1 (Referent) 1 (Referent) 69 1 (Referent) 1 (Referent) 1 (Referent) 1-SD increase ( ) 1.26 ( ) 1.23 ( ) ( ) 1.24 ( ) 1.22 ( ) Arteriolar diameters Quartile ( ) 1.11 ( ) 1.17 ( ) ( ) 1.13 ( ) 1.11 ( ) Quartiles (Referent) 1 (Referent) 1 (Referent) 82 1 (Referent) 1 (Referent) 1 (Referent) 1-SD decrease ( ) 0.96 ( ) 1.01 ( ) ( ) 1.00 ( ) 0.99 ( ) Retinal vessel diameters At risk (n) n Age and sex* RR RR n Age and sex* RR RR Gross proteinuria Renal insufficiency TABLE 2 RR of gross proteinuria and renal insufficiency in relation to retinal vessel diameter DIABETES, VOL. 53, JANUARY
4 RETINAL VESSEL DIAMETERS AND RENAL DYSFUNCTION TABLE 3 RR of gross proteinuria and renal insufficiency in relation to larger retinal venular diameter, stratified analysis At risk (n) Gross proteinuria Renal insufficiency n Age and sex* n Age and sex* Microalbuminuria Absent ( ) ( ) Present ( ) ( ) Any retinopathy Absent ( ) ( ) Present ( ) ( ) Proliferative retinopathy Absent ( ) ( ) Present ( ) ( ) Sex Male ( ) ( ) Female ( ) ( ) Current smoking Absent ( ) ( ) Present ( ) ( ) BMI 25 kg/m ( ) ( ) 25 kg/m ( ) ( ) Hypertension Absent ( ) ( ) Present ( ) ( ) Data are RR (95% CI) comparing 4th (largest) vs. 1st to 3rd venular diameter quartiles, adjusted for age, sex, and follow-up time, minus the stratifying variable for stratified analysis on sex. diabetes, glycemic control, blood pressure, and baseline retinopathy levels. This association was seen in eyes with and without any retinopathy or proliferative retinopathy. Retinal arteriolar diameter was not associated with diabetic renal disease. The association of larger venular diameter with incident gross proteinuria probably and renal insufficiency is consistent with other research that links more severe diabetic retinopathy with basement membrane thickening and changes in glomerular extracellular volume in experimental studies (9) and with incident gross proteinuria and renal failure in our previous analysis in the WESDR (11,12). Our data now suggest that retinal venular dilation, independent of more advanced retinopathy, is also related to the development of nephropathy in people with type 1 diabetes. This finding provides insights into possible mechanisms and pathogenesis of diabetic nephropathy. Cross-sectional data in the WESDR indicated that larger retinal venular diameter was associated with more severe diabetic retinopathy and independently with younger age, higher HbA 1c levels, longer duration of diabetes, higher BMI, and lower mean arterial blood pressure (23). Some of these observations are consistent with studies showing that larger venular diameters and increased blood flow are associated with diabetes status (19,21) and, in people with diabetes, with presence of retinopathy (17,18,20), higher HbA 1c levels (17), and longer duration of disease (22). However, there are no consistent explanations for these observations. One common hypothesis is that venular dilatation is related to hyperperfusion resulting from hyperglycemia (18,21). In eyes with retinopathy, venular dilation has been further hypothesized to be a result of lactic acidosis associated with retinal hypoxia (37). Thus, our finding that larger retinal venular diameter predicts risk of gross proteinuria and renal insufficiency, independent of duration and control of diabetes and retinopathy severity, suggests that microvascular processes resulting from hyperperfusion, ischemia, and other unmeasured factors may precede the development of nephropathy in people with type 1 diabetes. We did not find a significant association between retinal arteriolar diameter and risk of gross proteinuria or renal insufficiency. Data from the Atherosclerosis Risk in Communities study showed that in the general population, smaller retinal arteriolar diameter was related to chronically elevated blood pressure (38), systemic markers of inflammation (39), and incident diabetes (40), independent of known risk factors. In the WESDR, cross-sectional analysis showed an association between smaller arteriolar diameter and presence of gross proteinuria (23). However, this association was not present in the current prospective analysis. It is possible that individuals with retinal arteriolar narrowing and renal disease are more likely excluded due to selective mortality. The strengths of our study include a community-based population, long follow-up, quantitative and masked evaluation of retinal vessel diameters, and standardized measurement of renal dysfunction. Study limitations should be highlighted. First, retinal vessel data were available from the baseline study, whereas serum creatinine and gross proteinuria changes were determined from the second examination onwards. Selection bias due to mortality, nonparticipation, and other reasons for loss to follow-up cannot be excluded. For example, people with retinal arteriolar narrowing who developed fatal cardiovascular events may be excluded from the second examination onwards, which may result in nondifferential bias toward the null. Second, the study findings may be influenced by the methods used to collect and measure gross proteinuria 182 DIABETES, VOL. 53, JANUARY 2004
5 YIN WONG AND ASSOCIATES (11). For example, factors affected renal hemodynamics (e.g., medications, state of hydration, and dietary protein intake) may lead to false-positive dipstick urine test results. Additionally, use of a single measurement of gross proteinuria may lead to an overestimation of the incidence compared with use of multiple measurements over time. Third, we did not control for variations in pulsatility associated with the cardiac cycle or for other physiological factors. Assuming that the photographs were taken at random during the cardiac cycle, the resulting increase in variability of the grading might further result in an attenuation of our findings. However, variation in cardiac cycle has been estimated to contribute to only 6% of the total variation of arteriolar and venular diameters (41). Finally, it is unclear how these study findings may be applicable to type 2 diabetes and other ethnic groups (as 99% of this cohort was white). In summary, these population-based data show a prospective association of larger retinal venular diameter and risk of gross proteinuria and renal insufficiency, beyond that attributable to duration and control of diabetes, retinopathy severity, and other risk factors. These data support the concept that early retinal vessel caliber changes precede the development of diabetic nephropathy in people with type 1 diabetes and may provide independent predictive information regarding this complication. ACKNOWLEDGMENTS This study was supported by an American Diabetes Association Mentor based fellowship (to R.K.), National Institutes of Health (Bethesda, MD) Grant no. HL59259 (to R.K. and B.E.K.K.), and in part by Research to Prevent Blindness (New York, NY) (to R.K., Senior Scientific Investigator Award). REFERENCES 1. Perneger TV, Brancati FL, Whelton PK, Klag MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121: , Cooper ME: Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352: , Ritz E, Orth SR: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341: , Jensen T, Deckert T: Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients. Horm Metab Res Suppl 26:68 70, Skyler JS: Microvascular complications: retinopathy and nephropathy. Endocrinol Metab Clin North Am 30: , Raine AE, Bilous RW: End-stage renal disease in NIDDM: a consequence of microangiopathy alone? Diabetologia 39: , Joyner WL, Mayhan WG, Johnson RL, Phares CK: Microvascular alterations develop in Syrian hamsters after the induction of diabetes mellitus by streptozotocin. Diabetes 30:93 100, Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Batlle D: Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant 13: , Carlson EC: Scanning and transmission electron microscopic studies of normal and diabetic acellular glomerular and retinal microvessel basement membranes. Microscopy Res Techniq 28: , Cruickshanks KJ, Ritter LL, Klein R, Moss SE: The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 100: , Klein R, Klein BE, Moss SE, Cruickshanks KJ: Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 44: , Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC: The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 22: , Gall MA, Hougaard P, Borch-Johnsen K, Parving HH: Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 314: , Wirta O, Pasternack A, Mustonen J, Laippala P, Lahde Y: Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol 51: , The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342: , Kawagishi T, Nishizawa Y, Emoto M, Konishi T, Maekawa K, Hagiwara S, Okuno Y, Inada H, Isshiki G, Morii H: Impaired retinal artery blood flow in IDDM patients before clinical manifestations of diabetic retinopathy. Diabetes Care 18: , Falck A, Laatikainen L: Retinal vasodilation and hyperglycaemia in diabetic children and adolescents. Acta Ophthalmol Scand 73: , Patel V, Rassam S, Newsom R, Wiek J, Kohner E: Retinal blood flow in diabetic retinopathy. BMJ 305: , Feke GT, Buzney SM, Ogasawara H, Fujio N, Goger DG, Spack NP, Gabbay KH: Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 35: , Grunwald JE, DuPont J, Riva CE: Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol 80: , Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA: Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 37: , Konno S, Feke GT, Yoshida A, Fujio N, Goger DG, Buzney SM: Retinal blood flow changes in type I diabetes: a long-term follow-up study. Invest Ophthalmol Vis Sci 37: , Klein R, Klein BEK, Moss S, Wong TY, Hubbard LD, Cruickshanks KJ, Palta M: Retinal vascular abnormalities in persons with type 1 diabetes. The Wisconsin Epidemiological Study of Diabetic Retinopathy. XVIII. Ophthalmology 110: , Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: , Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: , Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107: , Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112: , Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Arch Ophthalmol 105: , Ravel R: Renal function tests. In Clinical Laboratory Medicine. Ravel R, Ed. New York, Mosby-Year Book, 1995, p Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR, Davis MD, Cai J: Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities (ARIC) Study. Ophthalmology 106: , National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory Board: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39 (2 Suppl. 2):S1 S246, Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: , Diabetic Retinopathy Study Research Group: Report number 7: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21: , Hypertension Detection and Follow-Up Program Cooperative Group: The hypertension detection and follow-up program. Prev Med 5: , Moss SE, Klein R, Klein BE, Spennetta TL, Shrago ES: Methodologic considerations in measuring HbA 1c in epidemiologic studies. J Clin Epidemiol 4: , 1988 DIABETES, VOL. 53, JANUARY
6 RETINAL VESSEL DIAMETERS AND RENAL DYSFUNCTION 36. D Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB: Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 9: , Keen H, Chlouverakis C: Metabolic factors in diabetic retinopathy. In Biochemistry of the Retina. Graymore CN, Ed. New York, Academic Press, 1965, p Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ, Nieto FJ, Pinsky JL, Klein R: Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 150: , Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS, Hubbard LD, Evans G: Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 20: , Wong TY, Klein R, Sharrett AR, Schmidt MI, Pankow JS, Couper DJ, Klein BE, Hubbard LD, Duncan BB: Retinal arteriolar narrowing and risk of diabetes in middle-aged persons. JAMA 287: , Knudtson MD, Klein BEK, Klein R, Wong TY, Hubbard LD, Lee KE, Meuer SM: Variation associated with retinal vessel diameter measurements controlling for known sources of variability. Br J Ophthalmol. In press 184 DIABETES, VOL. 53, JANUARY 2004
Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle
57 SCIENTIFIC REPORT Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle M D Knudtson, B E K Klein, R Klein, T Y Wong, L D Hubbard, K E Lee, S M Meuer,
More informationRetinal vessel calibre and micro- and macrovascular complications in type 1 diabetes
Diabetologia (2009) 52:2213 2217 DOI 10.1007/s00125-009-1459-8 SHORT COMMUNICATION Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes J. Grauslund & L. Hodgson & R. Kawasaki
More informationAssociation of Retinal Vessel Caliber to Optic Disc and Cup Diameters. Kristine E. Lee, Barbara Eden Kobrin Klein, Ronald Klein, and Stacy M.
Association of Retinal Vessel Caliber to Optic Disc and Cup Diameters Kristine E. Lee, Barbara Eden Kobrin Klein, Ronald Klein, and Stacy M. Meuer PURPOSE. To investigate whether optic disc size is related
More informationDiabetes Care 24: , 2001
Pathophysiology/Complications O R I G I N A L A R T I C L E Prevalence and Significance of Retinopathy in Subjects With Type 1 Diabetes of Less Than 5 Years Duration Screened for the Diabetes Control and
More informationDR as a Biomarker for Systemic Vascular Complications
DR as a Biomarker for Systemic Vascular Complications Lihteh Wu MD Asociados de Mácula, Vítreo y Retina de Costa Rica San José, Costa Rica LW65@cornell.edu Disclosures Dr Wu has received lecture fees from
More informationOptic Disc Cupping: Four Year Follow-up from the WESDR
Investigative Ophthalmology & Visual Science, Vol. 30, o., February 989 Copyright Association for Research in Vision and Ophthalmology Optic Disc Cupping: Four Year Follow-up from the WER Barbara E. K.
More informationMicrovascular Disease in Type 1 Diabetes
Microvascular Disease in Type 1 Diabetes Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine The Course
More informationORIGINAL INVESTIGATION. Retinal Vascular Changes and 20-Year Incidence of Lower Extremity Amputations in a Cohort With Diabetes
ORIGINAL INVESTIGATION Retinal Vascular Changes and 20-Year Incidence of Lower Extremity Amputations in a Cohort With Diabetes Scot E. Moss, MA; Ronald Klein, MD; Barbara E. K. Klein, MD; Tien Y. Wong,
More informationLongitudinal Studies of Incidence and Progression of Diabetic Retinopathy Assessed by Retinal Photography in Pima Indians
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Longitudinal Studies of Incidence and Progression of Diabetic Retinopathy Assessed by Retinal Photography in Pima Indians
More informationChanges in retinal vascular caliber may carry important
Measurement of Retinal Vascular Caliber: Issues and Alternatives to Using the Arteriole to Venule Ratio Gerald Liew, 1 A. Richey Sharrett, 2 Richard Kronmal, 3 Ronald Klein, 4 Tien Yin Wong, 5,6,7 Paul
More informationThe Relationship of Retinal Vascular Caliber with Diabetes and Retinopathy: The Multi-Ethnic Study of Atherosclerosis (MESA)
Diabetes Care Publish Ahead of Print, published online December 10, 2007 The Relationship of Retinal Vascular Caliber with Diabetes and Retinopathy: The Multi-Ethnic Study of Atherosclerosis (MESA) Thanh
More informationRetinal Arteriolar Dilation Predicts Retinopathy in Adolescents With Type 1 Diabetes
Pathophysiology/Complications O R I G I N A L A R T I C L E Retinal Arteriolar Dilation Predicts Retinopathy in Adolescents With Type 1 Diabetes NING CHEUNG, MBBS 1,2 SOPHIE L. ROGERS, MEPI 1 KIM C. DONAGHUE,
More informationThe retinal renin-angiotensin system: implications for therapy in diabetic retinopathy
(2002) 16, S42 S46 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh : implications for therapy in diabetic retinopathy AK Sjølie 1 and N Chaturvedi 2 1 Department
More informationDiabetes and Hypertension
Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for
More informationAssociation of retinal vessel calibre with diabetic retinopathy in an urban Australian Indigenous population *
Original Article Clinical Science Association of retinal vessel calibre with diabetic retinopathy in an urban Australian Indigenous population * Mohamed Dirani PhD, 1 Annie K McAuley BSc, 1 Louise Maple-Brown
More informationBlood Pressure Control and Diabetes
Blood Pressure Control and Diabetes Relationship Between Low-Normal Blood Pressure and Kidney Disease in Type 1 Diabetes Anoop Shankar, Ronald Klein, Barbara E.K. Klein, F. Javier Nieto, Scot E. Moss Abstract
More informationDiabetic retinopathy (DR) was first PROCEEDINGS DIABETIC RETINOPATHY * Ronald Klein, MD, MPH ABSTRACT
DIABETIC RETINOPATHY * Ronald Klein, MD, MPH ABSTRACT Diabetic retinopathy (DR) is characterized by the development of retinal microaneurysms, hemorrhages, deposits of leaked lipoproteins (hard exudates),
More informationAbnormalities of the retinal veins are. loops and reduplications in diabetic retinopathy. Prevalence, distribution, and pattern of development
Venous loops and reduplications in diabetic retinopathy Prevalence, distribution, and pattern of development Toke Bek Department of Ophthalmology, Århus University Hospital, DK-8000 Århus C, Denmark ABSTRACT.
More informationDiabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?
Retinopathy Diabetes has a negative effect on eyes in many ways, increasing the risk of cataracts for example, but the most common and serious ocular complication of diabetes is retinopathy. Diabetic retinopathy
More informationΟ ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη
Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη Κωνσταντίνος Τζιόμαλος Επίκουρος Καθηγητής Παθολογίας Α Προπαιδευτική Παθολογική Κλινική, Νοσοκομείο
More informationRetinal Vessel Calibers Predict Long-term Microvascular Complications in Type 1 Diabetes: The Danish Cohort of Pediatric Diabetes 1987 (DCPD1987)
3906 Diabetes Volume 63, November 2014 Rebecca Broe, 1,2,3 Malin L. Rasmussen, 1,2 Ulrik Frydkjaer-Olsen, 1,2 Birthe S. Olsen, 4,5 Henrik B. Mortensen, 4,5 Lauren Hodgson, 6 Tien Y. Wong, 6,7 Tunde Peto,
More informationDiabetologia 9 Springer-Verlag 1991
Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease
More informationNIH Public Access Author Manuscript Arch Ophthalmol. Author manuscript; available in PMC 2011 December 1.
NIH Public Access Author Manuscript Published in final edited form as: Arch Ophthalmol. 2010 December ; 128(12): 1568 1575. doi:10.1001/archophthalmol.2010.298. The 15-year Cumulative Incidence and Associated
More informationR etinal microvascular abnormalities, such as focal and
1007 CLINICAL SCIENCE Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study T Y Wong, L D Hubbard, R Klein, E K Marino, R Kronmal, A R Sharrett, D S Siscovick,
More informationAmin Aboali Hassan. Department Of Ophthalmology, Sohag University Hospital, Faculty of Medicine, Sohag University, Egypt
Three -Year Incidence and Risk Factors for Retinal Vein Occlusion in Sohag University Hospital Amin Aboali Hassan Department Of Ophthalmology, Sohag University Hospital, Faculty of Medicine, Sohag University,
More informationPrevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan
Prevention And Treatment of Diabetic Nephropathy MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan Prevention Tight glucose control reduces the development of diabetic nephropathy Progression
More informationRelationship of Retinal Vascular Caliber With Diabetes and Retinopathy. The Multi-Ethnic Study of Atherosclerosis (MESA)
Pathophysiology/Complications O R I G I N A L A R T I C L E Relationship of Retinal Vascular Caliber With Diabetes and Retinopathy The Multi-Ethnic Study of Atherosclerosis (MESA) THANH TAN NGUYEN, MBBS
More informationFactors Associated with Visual Outcome after Photocoagulation for Diabetic Retinopathy
Investigative Ophthalmology & Visual Science, Vol. 30, No. 1, January 1989 Copyright Association for Research in Vision and Ophthalmology Factors Associated with Visual Outcome after Photocoagulation for
More informationRelationship of Blood Pressure and Other Factors to Serial Retinal Arteriolar Diameter Measurements Over Time
EPIDEMIOLOGY SECTION EDITOR: LESLIE HYMAN, PhD Relationship of Blood Pressure and Other Factors to Serial Retinal Arteriolar Diameter Measurements Over Time The Beaver Dam Eye Study Ronald Klein, MD, MPH;
More informationRANZCO Screening and Referral Pathway for Diabetic Retinopathy #
RANZCO Screening and Referral Pathway for Diabetic Retinopathy # Patient Presents a. Screen for Diabetic Retinopathy every 2 years b. Begin screening at diagnosis of Diabetes * Clinical Modifi ers Yearly
More informationThe Association among Smoking, Heavy Drinking, and Chronic Kidney Disease
American Journal of Epidemiology Copyright ª 2006 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A. Vol. 164, No. 3 DOI: 10.1093/aje/kwj173 Advance Access publication
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationT he Joint National Committee on the Prevention, Detection,
1002 CLINICAL SCIENCE Hypertensive retinopathy and incident coronary heart disease in high risk men B B Duncan, T Y Wong, H A Tyroler, C E Davis, F D Fuchs... See end of article for authors affiliations...
More informationCONGESTIVE HEART FAILURE
ORIGINAL CONTRIBUTION Retinopathy and Risk of Congestive Heart Failure Tien Y. Wong, MD, PhD Wayne Rosamond, PhD Patricia P. Chang, MD, MHS David J. Couper, PhD A. Richey Sharrett, MD, DrPH Larry D. Hubbard,
More informationOptic Disc Cupping: Prevalence Findings from the WESDR
Investigative Ophthalmology & Visual Science, Vol., o. 2, February 1989 Copyright Association for Research in Vision and Ophthalmology Optic Disc Cupping: Prevalence Findings from the WER Barbara E. K.
More informationKidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain)
Kidney and heart: dangerous liaisons Luis M. RUILOPE (Madrid, Spain) Type 2 diabetes and renal disease: impact on cardiovascular outcomes The "heavyweights" of modifiable CVD risk factors Hypertension
More informationTHE PREVALENCE OF CAUSES FOR DIABETIC RETINOPATHY USING MATHEMATICAL MODELS
International Journal of Advanced Research in Engineering and Technology (IJARET) Volume 9, Issue 6, November-December 2018, pp. 167 171, Article ID: IJARET_09_06_017 Available online at http://www.iaeme.com/ijaret/issues.asp?jtype=ijaret&vtype=9&itype=6
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Control of Hypercholesterolaemia and Progression of Diabetic Nephropathy
Control of Hypercholesterolaemia and Progression of Diabetic Nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. All hypercholesterolaemic diabetics
More informationE.Ritz Heidelberg (Germany)
Predictive capacity of renal function in cardiovascular disease E.Ritz Heidelberg (Germany) If a cure is not achieved, the kidneys will pass on the disease to the heart Huang Ti Nei Ching Su Wen The Yellow
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationIn its initial report, the Early Treatment Diabetic Retinopathy. A Severity Scale for Diabetic Macular Edema Developed from ETDRS Data
A Severity Scale for Diabetic Macular Edema Developed from ETDRS Data Ronald E. Gangnon, 1,2 Matthew D. Davis, 3 Larry D. Hubbard, 3 Lloyd M. Aiello, 4 Emily Y. Chew, 5 Frederick L. Ferris III, 5 Marian
More informationRisk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study
Indian J Med Res 136, July 2012, pp 46-53 Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study Vijay Viswanathan, Priyanka Tilak
More information1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria
1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage
More informationSevere Hypoglycemia and Smoking in a Long-Term Type 1 Diabetic Population: Wisconsin Epidemiologic Study of Diabetic Retinopathy
Diabetes Care In Press, published online March 19, 2007 Severe Hypoglycemia and Smoking in a Long-Term Type 1 Diabetic Population: Wisconsin Epidemiologic Study of Diabetic Retinopathy Received for publication
More informationHypertension and diabetic nephropathy
Hypertension and diabetic nephropathy Elisabeth R. Mathiesen Professor, Chief Physician, Dr sci Dep. Of Endocrinology Rigshospitalet, University of Copenhagen Denmark Hypertension Brain Eye Heart Kidney
More informationDIABETIC RETINOPATHY AMONG TYPE 2 DIABETIC PATIENTS PRESENTING WITH MICROALBUMINURIA
ORIGINAL ARTICLE DIABETIC RETINOPATHY AMONG TYPE 2 DIABETIC PATIENTS PRESENTING WITH MICROALBUMINURIA Arshad Hussain 1, Iqbal Wahid 2, Danish Ali Khan 3 ABSTRACT INTRODUCTION: Diabetes mellitus is becoming
More informationDiabetic Retinopathy
Diabetic Retinopathy Overview This presentation covers the following topics: Definitions Epidemiology of diabetic retinopathy Evidence for public health approaches Screening for diabetic retinopathy Health
More informationThe prevalence of retinopathy in subjects with and without type 2 diabetes mellitus
The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus Eydis Olafsdottir, 1,2,3 Dan K. G. Andersson, 4 Inger Dedorsson 3 and Einar Stefa nsson 1,2 1 Department of Ophthalmology,
More informationImpaired protein tolerance test as a marker of early renal dysfunction in type 2 diabetes mellitus
Original Research Article Impaired protein tolerance test as a marker of early renal dysfunction in type 2 diabetes mellitus Devabhaktuni Siva Sankar 1, Shaik Khaja Rassul 1* 1 Assistant Professor of Medicine,
More informationRETINAL ARTERIOLAR NARrowing
CLINICAL SCIENCES Relationship of Retinal Vessel Caliber to Cardiovascular Disease and Mortality in African Americans With Type 1 Diabetes Mellitus Monique S. Roy, MD; Ronald Klein, MD; Malvin N. Janal,
More informationS150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153
S150 KEEP 2009 Analytical Methods American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153 S151 The Kidney Early Evaluation program (KEEP) is a free, communitybased health screening
More informationThe Retinal Microvasculature as a Model to Study. the Manifestations of Hypertension
The Retinal Microvasculature as a Model to Study the Manifestations of Hypertension ONLINE SUPPLEMENT Carol Yimlui Cheung, 1,2,3 M. Kamran Ikram, 1,2,3,4 Charumathi Sabanayagam, 1,2,3 Tien Yin Wong 1,2
More informationINTRODUCTION AND SYMPTOMS
CHAPTER 1 INTRODUCTION AND SYMPTOMS Introduction of Diabetic Retinopathy Diabetic retinopathy (DR) is a potentially blinding complication of diabetes. It is defined as presence of one or more definite
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES
Protein Restriction to prevent the progression of diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. A small volume of evidence suggests
More informationSerum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting glucose: The Rancho Bernardo Study
Diabetes Care Publish Ahead of Print, published online June 9, 2009 Serum uric acid and incident DM2 Serum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes can be classified into type 1 diabetes mellitus and type 2 diabetes mellitus, formerly known as insulin-dependent diabetes mellitus, and non-insulin diabetes mellitus, respectively.
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES
ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level
More informationAssessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation
Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation
More informationDiabetic Nephropathy
Diabetic Nephropathy Outline Introduction of diabetic nephropathy Manifestations of diabetic nephropathy Staging of diabetic nephropathy Microalbuminuria Diagnosis of diabetic nephropathy Treatment of
More informationRenal Protection Staying on Target
Update Staying on Target James Barton, MD, FRCPC As presented at the University of Saskatchewan's Management of Diabetes & Its Complications (May 2004) Gwen s case Gwen, 49, asks you to take on her primary
More informationDiabetic Nephropathy. Objectives:
There are, in truth, no specialties in medicine, since to know fully many of the most important diseases a man must be familiar with their manifestations in many organs. William Osler 1894. Objectives:
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationBlood Pressure, Lipids, and Obesity Are Associated With Retinopathy
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Blood Pressure, Lipids, and Obesity Are Associated With Retinopathy The Hoorn Study HENDRIK A. VAN LEIDEN, MD 1,2 JACQUELINE
More informationAccording to the US Renal Data System,
DIABETIC NEPHROPATHY * Mohamed G. Atta, MD ABSTRACT *Based on a presentation given by Dr Atta at a CME dinner symposium for family physicians. Assistant Professor of Medicine, Division of Nephrology, Johns
More informationLong-term outcomes in nondiabetic chronic kidney disease
original article http://www.kidney-international.org & 28 International Society of Nephrology Long-term outcomes in nondiabetic chronic kidney disease V Menon 1, X Wang 2, MJ Sarnak 1, LH Hunsicker 3,
More informationHypertension, Hypertension Control, and Chronic Kidney Disease in a Malay Population in Singapore
Asia Pac J Public Health OnlineFirst, published on May 10, 2010 as doi:10.1177/1010539510361637 Hypertension, Hypertension Control, and Chronic Kidney Disease in a Malay Population in Singapore Asia-Pacific
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES
Specific effects of calcium channel blockers in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Non-dihydropyridine calcium channel
More informationKidney International, Vol. 66 (2004), pp Report Number 7 (Ophthalmology 98: , 1991)
Kidney International, Vol. 66 (2004), pp. 1173 1179 Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report
More informationRetinal microvascular calibre and risk of diabetes mellitus: a systematic review and participant-level meta-analysis
Diabetologia (2015) 58:2476 2485 DOI 10.1007/s00125-015-3717-2 META-ANALYSIS Retinal microvascular calibre and risk of diabetes mellitus: a systematic review and participant-level meta-analysis Charumathi
More informationComplications of Diabetes mellitus. Dr Bill Young 16 March 2015
Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have
More informationEpidemiology and Pathophysiology of Diabetic Retinopathy
Epidemiology and Pathophysiology of Diabetic Retinopathy Vincent Reppucci, MD Director, Retina Service Mt. Sinai St. Luke s-roosevelt Hospital Attending Physician, Retina Service New York Eye and Ear Infirmary
More informationHypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality
Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality Tien Yin Wong* and Rachel McIntosh* *Centre for Eye Research Australia, University of Melbourne, Australia, and
More informationACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence?
Reviews ACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence? George L. Bakris, MD; 1 and Matthew Weir, MD 2 Although angiotensin-converting
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationAcute Effects of Different Intensities of Exercise in Normoalbuminuric/ Normotensive Patients With Type 1 Diabetes
Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Acute Effects of Different Intensities of Exercise in Normoalbuminuric/ Normotensive Patients With Type 1 Diabetes JAMES T. LANE, MD 1 TIMOTHY
More informationIncreased Risk of Renal Deterioration Associated with Low e-gfr in Type 2 Diabetes Mellitus Only in Albuminuric Subjects
ORIGINAL ARTICLE Increased Risk of Renal Deterioration Associated with Low e-gfr in Type 2 Diabetes Mellitus Only in Albuminuric Subjects Shu Meguro, Toshikatsu Shigihara, Yusuke Kabeya, Masuomi Tomita
More informationDiabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy
Diabetes in Renal Patients Contents Understanding Diabetic Nephropathy What effect does CKD have on a patient s diabetic control? Diabetic Drugs in CKD and Dialysis Patients Hyper and Hypoglycaemia in
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationDiabetes, particularly diabetic retinopathy, is
Chapter 14 Vision Disorders in Diabetes Ronald Klein, MD, MPH, and Barbara E.K. Klein, MD, MPH SUMMARY Diabetes, particularly diabetic retinopathy, is the leading cause of new cases of blindness in people
More informationEND-STAGE RENAL DISEASE (ESRD)
/ORIGINAL CONTRIBUTION Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus Holly J. Kramer, MD, MPH Quan Dong Nguyen, MD, MSc Gary Curhan, MD, ScD
More informationINTRODUCTION. In this study we examined the
GLYCEMIC CONTROL PREDICTS DIABETIC EXTRARENAL MICROVASCULAR COMPLICATIONS BUT NOT RENAL SURVIVAL IN PATIENTS WITH MODERATE TO SEVERE CHRONIC KIDNEY DISEASE Background: Control of blood pressure (BP) and
More informationEPIDEMIOLOGY. Retinal Emboli and Cardiovascular Disease. Ronald Klein, MD, MPH; Barbara E. K. Klein, MD, MPH; Scot E. Moss, MA; Stacy M.
Retinal Emboli and Cardiovascular Disease The Beaver Dam Eye Study EPIDEMIOLOGY Ronald Klein, MD, MPH; Barbara E. K. Klein, MD, MPH; Scot E. Moss, MA; Stacy M. Meuer, BS Objective: To describe the 10-year
More informationDIABETES MEASURES GROUP OVERVIEW
2014 PQRS OPTIONS F MEASURES GROUPS: DIABETES MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DIABETES MEASURES GROUP: #1. Diabetes: Hemoglobin A1c Poor Control #2. Diabetes: Low Density Lipoprotein (LDL-C)
More informationCLINICIAN INTERVIEW A REVIEW OF THE CURRENT TREATMENT MODALITIES FOR DIABETIC NEPHROPATHY. Interview with Ralph Rabkin, MD
A REVIEW OF THE CURRENT TREATMENT MODALITIES FOR DIABETIC NEPHROPATHY Interview with Ralph Rabkin, MD Dr Rabkin is Professor of Medicine, Emeritus, Active, at Stanford University School of Medicine, Stanford,
More informationFlicker-Light induced Retinal Vasodilation in Diabetes and Diabetic Retinopathy
Diabetes Care Publish Ahead of Print, published online July 29, 2009 Endothelial function in Diabetes & Retinopathy Flicker-Light induced Retinal Vasodilation in Diabetes and Diabetic Retinopathy Running
More informationSerum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy
The Journal of International Medical Research 2010; 38: 95 99 Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy Z-Z LI 1, X-Z LU 2, J-B LIU 1 AND L CHEN 1 1 Department of Endocrinology,
More informationA n aly tical m e t h o d s
a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.
More informationDiabetic Nephropathy
Diabetic Nephropathy Objectives: Know what Diabetic Nephropathy means. Know how common is Diabetic nephropathy in Saudi Arabia and to appreciate how bad are this complications. Know the risk factors of
More informationGuest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2
Public Health Live T 2 B 2 Chronic Kidney Disease in Diabetes: Early Identification and Intervention Guest Speaker Joseph Vassalotti, MD, FASN Chief Medical Officer National Kidney Foundation Thanks to
More informationMeasurement of glycated hemoglobin has long
ORIGINAL ARTICLE Glycated Hemoglobin and the Risk of Kidney Disease and Retinopathy in Adults With and Without Elizabeth Selvin, 1,2 Yang Ning, 3 Michael W. Steffes, 4 Lori D. Bash, 5 Ronald Klein, 6 Tien
More informationMicrovascular Complications in Diabetes:
Microvascular Complications in Diabetes: Perspectives on Glycemic Control to Prevent Microvascular Complications Discussion Outline: Glycemia and Microvascular Compliations Clinical Trials - A Brief History
More informationRetinopathy in a diabetic population
Kathmandu University Medical Journal (2007), Vol. 5, No. 2, Issue 18, 204-209 Retinopathy in a diabetic population Shrestha S 1, Malla OK 2, Karki DB 3, Byanju RN 4 2 Fellow of NAMS, 3 Professor, NAMS,
More informationEffects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus
Nephrol Dial Transplant (2005) 20: 2414 2419 doi:10.1093/ndt/gfi022 Advance Access publication 26 July 2005 Original Article Effects of smoking on renal function in patients with type 1 and type 2 diabetes
More informationDiabetic Retinopathy and Nephropathy
27 Diabetic Retinopathy and Nephropathy Ronald Klein, MD, MPH CONTENTS INTRODUCTION NATURAL HISTORY OF DIABETIC RETINOPATHY RELATIONSHIP OF DIABETIC NEPHROPATHY TO RETINOPATHY RELATIONSHIP OF DIABETIC
More informationMetformin should be considered in all patients with type 2 diabetes unless contra-indicated
November 2001 N P S National Prescribing Service Limited PPR fifteen Prescribing Practice Review PPR Managing type 2 diabetes For General Practice Key messages Metformin should be considered in all patients
More informationanger; anxiety; depression; microvessels; psychology, social; retina; social support
American Journal of Epidemiology ª The Author 2009. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail:
More informationRetinal vessel dilatation and elongation precedes diabetic macular oedema
274 Department of Ophthalmology, University of Iceland, Landakotsspítali, Reykjavík, Iceland K Kristinsson M S Gottfredsdóttir E Stefánsson Correspondence to: Einar Stefánsson, MD, PhD, University of Iceland,
More informationA pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy
A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy El-Orabi HA 1, Halawa MR 1, Abd El-Salam MM 1, Eliewa TF 2 and Sherif NSE 1 Internal Medicine and Endocrinology
More information